Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

JAK1 inhibitor may effectively treat alopecia areata when TNF-α inhibitors and corticosteroids fail.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

The document did not conclude on apremilast's effectiveness for severe alopecia areata.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.

Secukinumab and acitretin together may quickly and effectively treat severe generalized pustular psoriasis.

Risankizumab effectively treats and maintains skin clearance in moderate-to-severe psoriasis.

M50054 may help treat hepatitis and hair loss from chemotherapy.

Dupilumab effectively reduces alopecia areata symptoms in children with atopic dermatitis.

A woman's rare scalp condition worsened after using a specific arthritis medication, suggesting such medications can sometimes trigger or aggravate psoriasis.

Intralesional triamcinolone acetonide effectively treats acne keloidalis nuchae with minimal side effects.

Adalimumab may cause severe hair loss in some patients.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

Dupilumab helped a 13-year-old regrow hair after alopecia totalis.

Dupilumab may help children with alopecia areata and atopic dermatitis regrow hair.

Gemcitabine and Disitamab Vedotin effectively and safely reduced bladder cancer in a patient.

The rash resolved after stopping ponatinib.

Anti-CD19 therapy may help treat SLE and NMOSD.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

Efalizumab can cause unexpected excessive hair growth.

Tofacitinib can cause skin eruptions similar to palmoplantar pustulosis.

Ustekinumab and vedolizumab can help some ulcerative colitis patients with hair regrowth, but results vary.

AS101 reduces hair loss from chemotherapy.

A Labrador Retriever with pemphigus fully recovered after six weeks of azathioprine treatment.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Rituximab improved her dermatomyositis better than usual treatments.

Abatacept may help some people with alopecia areata regrow hair.

Adalimumab effectively stabilized severe folliculitis decalvans, preventing further hair loss and inflammation.